Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 3/20 | 0.49 |
| ▸ | APP | P05067 | 12/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-D-Glucose SCHEMBL383291 | 1.00 | SLC5A2 (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 | |
| Dextrose SCHEMBL5679244 | 1.00 | SLC5A2 (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 | |
| B-D-Galactose SCHEMBL8515088 | 1.00 | SLC5A2 (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 | |
| D-Galactose SCHEMBL2370315 | 1.00 | SLC5A2 (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 | |
| B-D-Galactose SCHEMBL1712843 | 1.00 | SLC5A2 (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 | |
| Beta-D-Glucose SCHEMBL3018938 | 0.87 | APP (0.68) | APPCYP1A2KDM4EMEN1ALDH1A1 | |
| D-Galactose SCHEMBL15391861 | 0.87 | APP (0.68) | APPCYP1A2KDM4EMEN1ALDH1A1 | |
| B-D-Galactose SCHEMBL307801 | 0.87 | APP (0.68) | APPCYP1A2KDM4EMEN1ALDH1A1 | |
| N-Acetylglucosamine SCHEMBL5692330 | 0.86 | HK1 (0.43) | SLC5A2APPCYP1A2POLB | |
| SCHEMBL3827094 | 0.85 | APP (0.49) | SLC5A2APPCYP1A2KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 947 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119147760-A | Single-molecule immunity detection method based on enzymatic reaction | 深圳栅极芯致生物科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118925814-A | Microfluidic chip, preparation method thereof and molecular measurement method using microfluidic chip | 上海交通大学 | 2024-11-12 | — | — | CN | claimed |
| US-20240159765-A1 | METHODS AND ARRAYS FOR TARGET ANALYTE DETECTION AND DETERMINATION OF TARGET ANALYTE CONCENTRATION IN SOLUTION | TRUSTEES OF TUFTS COLLEGE (US) | 2024-05-16 | — | — | US | claimed |
| CN-117929716-A | Endotoxin detection method based on single-molecule array immunoassay analyzer | 大连理工大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117761313-A | Single-molecule immunity detection method based on enzymatic reaction | 深圳栅极芯致生物科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117165655-A | Rapid pathogen-specific enzymatic drug sensitivity analysis method | 浙江大学 | 2023-12-05 | — | — | CN | claimed |
| US-20230035402-A1 | MISFOLDED SOD1 ASSAY | AL-S PHARMA AG (CH) | 2023-02-02 | — | — | US | claimed |
| US-20220187322-A1 | USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES | H. LUNDBECK A/S (DK) | 2022-06-16 | — | — | US | claimed |
| US-20220099678-A1 | METHODS AND ARRAYS FOR TARGET ANALYTE DETECTION AND DETERMINATION OF TARGET ANALYTE CONCENTRATION IN SOLUTION | TRUSTEES OF TUFTS COLLEGE (US) | 2022-03-31 | — | — | US | claimed |
| EP-3948295-A1 | USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES | H. Lundbeck A/S (DK) | 2022-02-09 | — | — | EP | claimed |
| US-6207398-B1 | LYSING RED BLOOD CELLS IN A SAMPLE OF WHOLE BLOOD CONTAINING CYCLOSPORIN A, CONTACTING THE SAMPLE WITH EXCESS OF LABELED ANTI-CYCLOSPORIN ANTIBODY TO FORM A COMPLEX, SEPARATING UNBOUND ANTIBODY, CONTACTING COMPLEX WITH CYCLOSPORINS | DADE BEHRING INC. | 2001-03-27 | — | — | US | claimed |
| US-5604091-A | ENZYME DONOR POLYPEPTIDE HAVING SPECIFIED AMINO ACID SEQUENCE; QUALITATIVE AND QUANTITATIVE ANALYSIS | MICROGENICS CORPORATION (US) | 1997-02-18 | — | — | US | claimed |
| EP-0428137-B1 | Procedure for the enhancement of the enzymatic reactivity of beta-galactosidase | BOEHRINGER MANNHEIM GMBH (DE) | 1995-06-28 | — | — | EP | claimed |
| US-5194382-A | Method for increasing the enzymatic reactivity of β-galactosidase by addition of a cyanate, thiocyanate, azide, or thiosulfate compound | BOEHRINGER MANNHEIM GMBH (DE) | 1993-03-16 | — | — | US | claimed |
| EP-0375454-B1 | ENZYME-LINKED IMMUNOASSAY FOR MEASUREMENT OF CYCLOSPORIN A LEVELS IN WHOLE BLOOD SAMPLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-03-10 | — | — | EP | claimed |
| US-5151348-A | Lysis red blood cells, contacting with galactosidase labeled anticyclosporin antibodies | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-29 | — | — | US | claimed |
| US-5055390-A | Amphiphilic compound migrating into droplet, interacting with biological entity; measuring fluorescence | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-10-08 | — | — | US | claimed |
| EP-0199801-A4 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS. | MICROGENICS CORP (US) | 1988-12-15 | — | — | EP | claimed |
| EP-0199801-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS. | MICROGENICS CORP (US) | 1986-11-05 | — | — | EP | claimed |
| WO-1986002666-A1 | METHODS FOR PROTEIN BINDING ENZYME COMPLEMENTATION ASSAYS | MICROGENICS CORPORATION (US) | 1986-05-09 | — | — | WO | claimed |